Epithelial tissues in which carcinomas develop often contain systemically derived T cell receptor (TCR)αβ+ cells and resident intraepithelial lymphocytes that are commonly enriched in TCRγδ+ cells. Recent studies have demonstrated that γδ cells protect the host against chemically induced cutaneous malignancy, but the role of αβ T cells has been enigmatic, with both protective and tumor-enhancing contributions being reported in different systems. This study aims to clarify the contributions of each T cell type to the regulation of squamous cell carcinoma induced in FVB mice by a two-stage regimen of 7,12-dimethylbenz[a]anthracene initiation followed by repetitive application of the tumor promoter 12-O-tetradecanoylphorbol 13-acetate. This protocol permits one to monitor the induction of papillomas and the progression of those papillomas to carcinomas. The results show that whereas γδ cells are strongly protective, the nonredundant contributions of αβ T cells to the host's protection against papillomas are more modest. Furthermore, at both high and low doses of carcinogens, αβ T cells can contribute to rather than inhibit the progression of papillomas to carcinomas. As is likely to be the case in humans, this study also shows that the contribution of T cells to tumor immunosurveillance is regulated by modifier genes.
Skip Nav Destination
Article navigation
1 September 2003
Article Contents
Article|
September 02 2003
The Distinct Contributions of Murine T Cell Receptor (TCR)γδ+ and TCRαβ+ T Cells to Different Stages of Chemically Induced Skin Cancer
Michael Girardi,
Michael Girardi
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
Search for other works by this author on:
Earl Glusac,
Earl Glusac
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
Search for other works by this author on:
Renata B. Filler,
Renata B. Filler
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
Search for other works by this author on:
Scott J. Roberts,
Scott J. Roberts
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
Search for other works by this author on:
Iva Propperova,
Iva Propperova
3Department of Dermatology and Venereology, Motal University Hospital, 150 06 Prague 5, Czech Republic
Search for other works by this author on:
Julia Lewis,
Julia Lewis
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
Search for other works by this author on:
Robert E. Tigelaar,
Robert E. Tigelaar
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
2Section of Immunobiology, Yale University, New Haven, CT 06520
Search for other works by this author on:
Adrian C. Hayday
Adrian C. Hayday
4Peter Gorer Department of Immunobiology, Guy's King's St. Thomas' School of Medicine, Guy's Hospital, SE1 9RT London, United Kingdom
Search for other works by this author on:
Michael Girardi
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
Earl Glusac
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
Renata B. Filler
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
Scott J. Roberts
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
Iva Propperova
3Department of Dermatology and Venereology, Motal University Hospital, 150 06 Prague 5, Czech Republic
Julia Lewis
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
Robert E. Tigelaar
1Department of Dermatology and the Yale Skin Diseases Research Core Center, Yale University, New Haven, CT 06520
2Section of Immunobiology, Yale University, New Haven, CT 06520
Adrian C. Hayday
4Peter Gorer Department of Immunobiology, Guy's King's St. Thomas' School of Medicine, Guy's Hospital, SE1 9RT London, United Kingdom
Address correspondence to Adrian Hayday, Guy's King's St. Thomas' School of Medicine, Peter Gorer Department of Immunobiology, 3rd Floor, New Guy's House, Guy's Hospital, SE1 9RT London, United Kingdom. Phone: 44-20-7955-4355; Fax: 44-20-7955-8894; email: [email protected]
Abbreviations used in this paper: DETC, dendritic epidermal T cell; DMBA, 7,12-dimethylbenz[a]anthracene; FLHSC, fetal liver hematopoetic stem cell; IEL, intraepithelial lymphocyte; NMSC, nonmelanoma skin cancer; SCC, squamous cell carcinoma; TPA, 12-O-tetradecanoylphorbol 13-acetate.
Received:
July 30 2002
Revision Received:
July 02 2003
Accepted:
July 11 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (5): 747–755.
Article history
Received:
July 30 2002
Revision Received:
July 02 2003
Accepted:
July 11 2003
Citation
Michael Girardi, Earl Glusac, Renata B. Filler, Scott J. Roberts, Iva Propperova, Julia Lewis, Robert E. Tigelaar, Adrian C. Hayday; The Distinct Contributions of Murine T Cell Receptor (TCR)γδ+ and TCRαβ+ T Cells to Different Stages of Chemically Induced Skin Cancer . J Exp Med 1 September 2003; 198 (5): 747–755. doi: https://doi.org/10.1084/jem.20021282
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement